AIC
NMTC icon

AWM Investment Company’s NeuroOne Medical Technologies NMTC Stock Holding History

AWM Investment Company’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-152,778
Closed -$815K – 109
2025
Q3 		$815K Buy
+152,778
New +$748K 0.08% 95

Other funds holding NMTC

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AWM Investment Company's NMTC Position: Q4 2025 in Review

AWM Investment Company sold out of NeuroOne Medical Technologies (NMTC) in Q4 2025, closing a stake of 152,778 shares — an estimated $815K sold.

AWM Investment Company first reported a position in NMTC in Q3 2025 and held it in 1 quarter. The position peaked at $815K in Q3 2025. 37 funds tracked by Wall St. Rank hold NMTC as of Q4 2025.

  • AWM Investment Company reported no remaining NeuroOne Medical Technologies position as of Q4 2025 after selling out during the quarter.
  • AWM Investment Company sold 152,778 NeuroOne Medical Technologies shares in Q4 2025, an estimated $815K.
  • AWM Investment Company first reported a position in NeuroOne Medical Technologies in Q3 2025 and held it in 1 quarter.
  • AWM Investment Company's NeuroOne Medical Technologies position peaked at $815K in Q3 2025.
  • 37 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q4 2025.

Based on AWM Investment Company's 13F filing for Q4 2025, filed 13 Feb 2026.